SNPMiner Trials by Shray Alag


SNPMiner SNPMiner Trials (Home Page)


Report for Mutation C19P

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

There is one clinical trial.

Clinical Trials


1 COVID-19 Phobia and Quality of Life in Patients With Bronchiectasis During Covid-19 Pandemic

In the literature, there are no studies evaluating COVID-19 phobia, quality of life, health anxiety, physical activity level and quality of sleep in patients with bronchiectasis during COVID-19 pandemic. The investigators will evaluate these parameters in patients with bronchiectasis and compare the findings of healthy individuals during COVID-19 pandemic

NCT04487873 Covid19 Bronchiectasis
MeSH:Bronchiectasis
HPO:Bronchiectasis

COVID-19 phobia was evaluated with COVID-19 Phobia Scale (C19P-S) and total score ranges from 20-100. --- C19P ---

Primary Outcomes

Description: COVID-19 phobia was evaluated with COVID-19 Phobia Scale (C19P-S) and total score ranges from 20-100. Lower scores mean better outcome.

Measure: COVID-19 Phobia

Time: 5 minutes

Description: Quality of life was evaluated with Nottingham Health Profile

Measure: Qol

Time: 10 minutes

Secondary Outcomes

Description: Health anxiety was evaluated with Health Anxiety Inventory

Measure: Health anxiety

Time: 10 minutes

Description: Physical activity level was evaluated with International Physical Activity Questionnaire - Short Form (IPAQ-SF)

Measure: Physical activity

Time: 5 minutes

Description: Quality of sleep was evaluated with Pittsburgh Sleep Quality Index

Measure: Quality of sleep

Time: 10 minutes


HPO Nodes